AC magnetic-field-induced heating and physical properties of ferrite nanoparticles for a hyperthermia agent in medicine

IEEE Transactions on Nanotechnology

Volumn 8, Issue 1, 2009, Pages 86-94

  Bae, Seongtae ^a   Lee, Sang Won ^a   Hirukawa, Atsuo ^b   Takemura, Yasushi ^b   Jo, Youn Haeng ^c   Lee, Sang Geun ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b YOKOHAMA NATIONAL UNIVERSITY   (Japan)

^c Industry and Energy   (South Korea)

Author keywords

AC magnetic field induced heating; Biocompatibility; Ferrite nanoparticles; In vivo hyperthermia agent; Magnetic susceptibility

Indexed keywords

AMINES; BIOCOMPATIBILITY; CLARIFICATION; FERRITE; HEATING; HYSTERESIS; MAGNETIC FIELDS; MAGNETIC PROPERTIES; MAGNETIC SUSCEPTIBILITY; MAGNETISM; NANOPARTICLES; PARTICLE SIZE; POLYSACCHARIDES;

AC MAGNETIC FIELDS; AC MAGNETIC-FIELD-INDUCED HEATING; APPLIED MAGNETIC FIELDS; CYTOTOXICITY TESTS; FERRITE NANOPARTICLES; HEATING TEMPERATURES; IN VIVO HYPERTHERMIA AGENT; LOW MAGNETIC FIELDS; MAGNETIC NANOPARTICLES; MAGNETICALLY-INDUCED HEATING; MEAN PARTICLE SIZES; MINOR HYSTERESIS LOOPS; PHYSICAL ANALYSIS; SPINEL-FERRITE NANOPARTICLES; TEST METHODS;

MAGNETIC MATERIALS;

EID: 59049105401     PISSN: 1536125X     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNANO.2008.2007214     Document Type: Article

References (23)

1. R. K. Gilchrist, R. Medal, W. D. Shorey, R. C. Hanselman, J. C. Parrott, and C. B. Taylor, "Selective inductive heating of lymph nodes," Ann. Surg., vol. 146, pp. 596-606, 1957.
2. P. Moroz, S. K. Jones, and B. N. Gray, "Magnetically mediated hyperthermia: Current status and future directions." Int. J. Hypertherm., vol. 18, pp. 267-284, 2002.
3. C. Guiot, E. Madon, D. Allegro, P. G. Pianta, B. Baiotto, and P. Gabriele, "Perfusion and thermal field during hyperthermia. Experimental measurements and modeling in recurrent breast cancer," Phys. Med. Biol., vol. 43, pp. 2831-2843, 1998.
4. A. Jordan, P. Wust, H. Fahling, W. John, A. Jinz, and R. Felix, "Inductive heating of ferrimagnetic nanoparticles magnetic fluids: Physical evaluation of their potential for hyperthermia," Int. J. Hypertherm., vol. 9, pp. 51-68, 1993.
5. P. Moroz, S. K. Johns, and B. N. Gray, "Status of hyperthermia in the treatment of advanced liver cancer," J. Surg. Oncol., vol. 71, pp. 259-269, 2001.
6. P. Burgman, A. Nusenzweig, G. C. Li, M. H. Seegenschmiedt, P. Fesseden, and C. C. Vernon, Thermo-Radiotheraphy and Theimochemo-Therapy, vol. I, Biology, Physiology, Physics. Berlin, Germany: Springer-Verlag, 1995.
7. J. R. Oleson, T. C. Cetas, and P. M. Cony, "Hyperthermia by magnetic induction: Experimental and theoretical results for coaxial coil pairs," Radial. Res., vol. 95, pp. 175-186, 1983.
8. Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, "Applications of magnetic nanoparticles in biomedicine," J. Phys. D, vol. 36, pp. R167-R181.2003.
9. M. Morita, T. Inoue, T. Yamada, Y. Takemura, T. Niwa, and T. lnoue, "Resonance circuit for hyperthermia excited by RF magnetic field of MRI," IEEE Trans. Magn., vol. 41, no. 10, pp. 3673-3675, Oct. 2005.
10. 4 with a few nanometers," J. Magn. Magn. Mater., vol. 303, pp. e315-e317, 2006.
11. A. K. Gupta and M. Gupta, "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications," Biomaterials, vol. 26, pp. 3995-4021, 2005.
12. R. E. Rosensweig, "Heating magnetic fluid with alternating magnetic field," J. Magn. Magn. Mater., vol. 252, pp. 370-374, 2002.
13. R. Hergt, W. Andra, C. G. d'Ambly, I. Hilger, W. A. Kaiser, U. Rtcheter, and H. G. Schmidt, "Physical limit of hyperthermia using magnetite fine particles," IEEE Trans. Magn., vol. 34, no. 5, pp. 3745-3754, Sep. 1998.
14. A. Hirukawa, T. Yamada, Y. Takemura, S. Bae, and S. W. Lee, "Hysteresis loss in self-heating temperature rising of magnetic nanoparticles for hyperthermia applications," in Proc. 2007 Int. Symp. Adv. Magn. Mater. Appl., Jeju, Korea, Paper QD-08, p. 95.
15. J. Smit and H. P. J. Wijn, Ferrite. Eindhoven, The Netherlands: Philips Tech. Bibliotech, 1962.
16. C. K. Chou, "Use of heating rate and specific absorption rate in the hyperthermia clinic," Int. J. Hypertherm., vol. 6, pp. 367-370, 1990.
17. 4 particles in hyperthermia." J. Magn. Magn. Mater., vol. 307, pp. 85-90, 2006.
18. 4." J. Phys. Chem. Solids, vol. 68, pp. 10-21, 2007.
19. 4 nanoparticles for a hyperthermia agent in biomedicine," Appl. Phys. Lett., vol. 89, pp. 252503-1-252503-3, 2006.
20. T. Maehara, K. Konishi, T. Kamimori, H. Aono, H. Horazawa, T. Naohara, S. Nomura, H. Kikkawa, Y. Watanabe, and K. Kawachi, "Selection of ferrite powder for thermal coagulation therapy with alternating magnetic field," J. Mater. Sci., vol. 40, pp. 135-138, 2005.
21. W. J. Atkinson, I. A. Brezovichi, and D. P. Charaboty. "Usable frequencies in hyperthermia with thermal seeds," IEEE Trans. Biomed. Eng., vol. BME-31, no. 1, pp. 70-75, Jan. 1984.
22. J. R. Oleson, R. S. Heusinkveld, and M. R. Manning, "Hyperthermia by induction: II, Clinical experience with concentric electrodes," Int. J. Radial. Oncol., Biol. Phys., vol. 9, pp. 549-556, 1983.
23. A. Jordan, R. Scholz, P. Wust, H. Fahling, and R. Felix, "Magnetic fluid hyperthermia (MFH): Cancer treatment with ac magnetic field induced excitation of biocompatible superparamagentic nanoparticles," J. Magn. Magn. Mater., vol. 201, pp. 413-419, 1999.